How to Cite
Abstract
Analysis of mammoscintigraphy is presented to assess the effectiveness of neoadjuvant polychemotherapy for locally advanced breast cancer. In 90% of patients there is defined conformity of scintigraphy data on the effectiveness of performed polychemotherapy to the results of histologic examination of the postoperative material. The sensitivity of scintigraphy in assessing the effectiveness of neoadjuvant polychemoterapy was 83.3%, specificity—87.9%, accuracy—86.3%, predictive value of positive and negative results—78.9% and 90.1%, respectively. Mammoscintigraphy is an effective method to control the response of locally advanced breast cancer to neoadjuvant polychemotherapy.References
Ciarmiello A., DelVecchio S., Potena M. et al. 99m-Tc-sestamibi efflux and therapeutic response in patients with advanced breast carcinoma // Exper Therap. - 1996. - Vol. 37. - P 2107.
Dunnwald L.K., Gralow J.R., Ellis G.K. et al. Residual tumor uptake of [99mTc]-sestamibi after neoadjuvant chemotherapy for locally advanced breast carcinoma predicts survival // Cancer (Philad). — 2005. — Vol. 103. - P 680-688.
Hortobagyi G.N., Blumenschein G.R., Spanos W. et al. Multimodality treatment of locoregionally advanced breast cancer // ibid. - 1983. - Vol. 51. - P. 763-768.
Maini C.L., Tofani A., Sciuto R. et al. Technecium-99m-MIBI scintigraphy in assessment of neoadjuvant chemotherapy in breast carcinoma // J. Nucl. Med. — 1997. — Vol. 38. - P. 1546-1551.
Mankoff D., Gralow J., Dunnwald L. et al. Tc-99m-sestamibi scintimammography to measure the breast cancer response to neo-adjuvant chemotherapy // J. Nucl. Med. — Proceeding of the 43rd annual meeting, June 3-5, Denver, Colorado. — 1996. — P 1130.
Massardo T., Alonso O., Llamas-Ollier A. et al. Planar Tc99m-sestamibi scintimammography should be considered cautiously in the axillary evaluation of breast cancer protocol: results of an international multicenter trial // BMC Nuclear Medicine. — 2005. — Vol. 5. — P. 1-7.
Mathieu I., Mazy S., Willemart B. et al. Inconclusive triple diagnosis in breast cancer imaging: is there a place for scintimammography // J. Nucl. Med. — 2005. — Vol. 46. - P. 1574-1581.
Ogston K.N., Miller I.D., Payne S. et al. A new histological grading system to assess response of breast cancers to primary chemotherapy: Prognostic significance and survival // Breast 2003. - Vol. 12/ - P 320-327.
Schillaci O., Danieli R., Filippi L. et al. Scintimammography with a hybrid SPECT/CT imaging system // Anticancer Research. - 2007. - Vol. 27. - P. 557-562.
All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...